These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 106773)

  • 1. Outer-membrane penetration barriers as components of intrinsic resistance to beta-lactam and other antibiotics in Escherichia coli K-12.
    Scudamore RA; Beveridge TJ; Goldner M
    Antimicrob Agents Chemother; 1979 Feb; 15(2):182-9. PubMed ID: 106773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration through the gram-negative cell wall: a co-determinant of the efficacy of beta-lactam antibiotics.
    Zimmermann W
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):131-4. PubMed ID: 107128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of Escherichia coli to various beta-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic beta-lactamases: a quantitative predictive treatment.
    Nikaido H; Normark S
    Mol Microbiol; 1987 Jul; 1(1):29-36. PubMed ID: 3330755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J; Heleszko H
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in gram-negative bacteria.
    Sawai T; Yamaguchi A; Hiruma R
    Rev Infect Dis; 1988; 10(4):761-4. PubMed ID: 3055174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial compounds of Canadian honeys target bacterial cell wall inducing phenotype changes, growth inhibition and cell lysis that resemble action of β-lactam antibiotics.
    Brudzynski K; Sjaarda C
    PLoS One; 2014; 9(9):e106967. PubMed ID: 25191847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relations of 5,6-cis carbapenem antibiotics and role of factors determining susceptibility of Escherichia coli to beta-lactam antibiotics.
    Nozaki Y; Harada S; Kitano K; Imada A
    J Antibiot (Tokyo); 1984 Mar; 37(3):218-26. PubMed ID: 6373699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited contribution of the outer-membrane penetration barrier towards intrinsic antibiotic resistance of Pseudomonas aeruginosa.
    Scudamore RA; Goldner M
    Can J Microbiol; 1982 Feb; 28(2):169-75. PubMed ID: 6461406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
    Hashizume T; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504
    [No Abstract]   [Full Text] [Related]  

  • 10. Murein and the outer penetration barrier of Escherichia coli K-12, Proteus mirabilis, and Pseudomonas aeruginosa.
    Burman LG; Nordström K; Bloom GD
    J Bacteriol; 1972 Dec; 112(3):1364-74. PubMed ID: 4629657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of the outer membrane of Pseudomonas aeruginosa by synergistic combinations of beta-lactam and aminoglycoside antibiotics.
    Scudamore RA; Goldner M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1007-10. PubMed ID: 6810756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeation of beta-lactam antibiotics into Escherichia coli, Pseudomonas aeruginosa, and other gram-negative bacteria.
    Livermore DM
    Rev Infect Dis; 1988; 10(4):691-8. PubMed ID: 3142011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Escherichia coli K-12 by beta-lactam antibiotics with poor antibacterial activity: interaction of permeability and intrinsic activity against penicillin-binding proteins.
    Curtis NA; Brown C; Boxall M; Boulton MG
    Antimicrob Agents Chemother; 1979 Mar; 15(3):332-6. PubMed ID: 380457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetrability of the outer membrane of Neisseria gonorrhoeae in relation to acquired resistance to penicillin and other antibiotics.
    Scudamore RA; Beveridge TJ; Goldner M
    Antimicrob Agents Chemother; 1979 Jun; 15(6):820-7. PubMed ID: 112915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for evaluating the outer membrane permeability to beta-lactamase-stable beta-lactam antibiotics.
    Kojo H; Shigi Y; Nishida M
    J Antibiot (Tokyo); 1980 Mar; 33(3):310-6. PubMed ID: 6991466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeability and susceptibility of Escherichia coli to beta-lactam compounds.
    Clark D
    Antimicrob Agents Chemother; 1981 Feb; 19(2):369-70. PubMed ID: 6751219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics.
    Coulton JW; Mason P; Dorrance D
    J Antimicrob Chemother; 1983 Nov; 12(5):435-49. PubMed ID: 6608514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of beta-lactamases and the permeability barrier in resistance to beta-lactam antibiotics].
    Perduca M; Pagani L; Romero E
    Boll Ist Sieroter Milan; 1985; 64(4):281-4. PubMed ID: 3935134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bacterial outer-membrane permeability of beta-lactam antibiotics.
    Sawai T; Matsuba K; Tamura A; Yamagishi S
    J Antibiot (Tokyo); 1979 Jan; 32(1):59-65. PubMed ID: 368002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of defined cell envelope mutations in Escherichia coli on the in vitro antibacterial activity of avibactam/β-lactam combinations.
    McLeod SM; Patey SA; Huband MD; Nichols WW
    Int J Antimicrob Agents; 2017 Apr; 49(4):437-442. PubMed ID: 28242258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.